Quest Diagnostics (DGX) cash: $420M
Quest Diagnostics held $420M in cash and cash equivalents on Dec 31, 2025, down 23.5% from $549M a year earlier.
From Quest Diagnostics's filings with the SEC · Read the filing · DGX stock page
Quest Diagnostics cash by year
#981 of 4,171 US companies by cash · See the full ranking
| Year ended | Cash | Change |
|---|---|---|
| Dec 31, 2025 | $420M | -23% |
| Dec 31, 2024 | $549M | -20% |
| Dec 31, 2023 | $686M | +118% |
| Dec 31, 2022 | $315M | -64% |
| Dec 31, 2021 | $872M | – |
Cash of similar companies
Companies in the same industry as Quest Diagnostics, by SEC industry code, with the closest cash. Each name opens the same page for that company.
| Company | Cash, latest year | Year ended |
|---|---|---|
| RadNet | $767M | Dec 31, 2025 |
| Labcorp | $532M | Dec 31, 2025 |
| BillionToOne | $496M | Dec 31, 2025 |
| Quest Diagnostics | $420M | Dec 31, 2025 |
| Guardant Health | $378M | Dec 31, 2025 |
| Veracyte | $363M | Dec 31, 2025 |
| GRAIL | $250M | Dec 31, 2025 |
Questions and answers
What is Quest Diagnostics's cash?
Quest Diagnostics held $420M in cash and cash equivalents on Dec 31, 2025, down 23.5% from $549M a year earlier.
Numbers as reported in Quest Diagnostics's annual and quarterly reports to the SEC (XBRL data). A year is the company's fiscal year that falls mostly in that calendar year; balances such as cash and debt are as of the date shown. Data only, not investment advice. Methodology